Search - tctmd.com

Displaying 1 - 20 of 72

Sort: Relevancy | Date

Presentation TCT 2024

Welcome, Clinical Rationale of Bioadaptive PCI

Presenter: Dean Kereiakes

October 30, 2024

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

Shelley Wood

February 16, 2021

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

Presentation TCT 2020

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

Presenter: Dean Kereiakes

October 17, 2020

The OPTIMIZE IDE: TrialProspective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presentation TCT 2020

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presenter: Dean J. Kereiakes

October 17, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

Presentation TCT 2020

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

Presenter: Dean J. Kereiakes

October 15, 2020

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

Presentation SIF 2019

Left Main Coronary Revascularization at the Crossroads: The Evolving Role of PCI

Presenter: Dean J. Kereiakes

March 28, 2019

Presentation SIF 2019

Novel Coronary Stent Platforms: Innovations to Improve Clinical Outcomes

Presenter: Dean J. Kereiakes

March 28, 2019

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

Presentation Cardiovascular Interventions 2018

DAPT in Evolution: 2018

Presenter: Dean J. Kereiakes

October 26, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB III 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Dean J. Kereiakes

September 22, 2018

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes

September 21, 2018

Presentation Cardiovascular Interventions 2017

BP-DES Update: SYNERGY and Beyond

Presenter: Dean J. Kereiakes

November 10, 2017

Presentation Cardiovascular Interventions 2017

DAPT Duration After Stenting: An Updated Appraisal

Presenter: Dean J. Kereiakes

November 09, 2017

News Conference News TCT 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

Todd Neale

November 01, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

Advertisement

Welcome, Clinical Rationale of Bioadaptive PCI

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Left Main Coronary Revascularization at the Crossroads: The Evolving Role of PCI

Novel Coronary Stent Platforms: Innovations to Improve Clinical Outcomes

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

DAPT in Evolution: 2018

ABSORB Beyond 3 Years: ABSORB III 4-Year Data

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

BP-DES Update: SYNERGY and Beyond

DAPT Duration After Stenting: An Updated Appraisal

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content